Investing.com -- Bernstein lifted its price target on a European drugmaker and maintained its “Underperform” rating, warning the obesity-drug giant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE